{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:32:24Z","timestamp":1792017144839,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ymthe.2020.01.002","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T20:28:44Z","timestamp":1578601724000},"page":"805-819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV"],"prefix":"10.1016","volume":"28","author":[{"given":"Kevin E.","family":"Lindsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryll","family":"Vanover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrilee","family":"Thoresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peres","family":"Badial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariluz","family":"Ara\u00ednga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Bin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja M.","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmeline L.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Feugang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia K.","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zurla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Villinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia R.","family":"Woolums","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.01.002_bib1","author":"UNAIDS"},{"key":"10.1016\/j.ymthe.2020.01.002_bib2","doi-asserted-by":"crossref","first-page":"e1006313","DOI":"10.1371\/journal.ppat.1006313","article-title":"Predicting HIV-1 transmission and antibody neutralization efficacy in\u00a0vivo from stoichiometric parameters","volume":"13","author":"Brandenberg","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2020.01.002_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/COH.0b013e32833a0d3a","article-title":"Role of acute and early HIV infection in the sexual transmission of HIV","volume":"5","author":"Miller","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.ymthe.2020.01.002_bib4","doi-asserted-by":"crossref","unstructured":"Zimmerman, P.A., Buckler-White, A., Alkhatib, G., Spalding, T., Kubofcik, J., Combadiere, C., Weissman, D., Cohen, O., Robbert, A., Lam, G., et\u00a0al. Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk. Molecular Medicine 3, 23\u201336.","DOI":"10.1007\/BF03401665"},{"key":"10.1016\/j.ymthe.2020.01.002_bib5","doi-asserted-by":"crossref","first-page":"e1004440","DOI":"10.1371\/journal.ppat.1004440","article-title":"Vaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tract","volume":"10","author":"Stieh","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2020.01.002_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/653620","article-title":"Finally, a macaque model for cell-associated SIV\/HIV vaginal transmission","volume":"202","author":"Anderson","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2020.01.002_bib7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2016.03.021","article-title":"Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus Monkeys","volume":"165","author":"Barouch","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.01.002_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ebiom.2016.11.024","article-title":"Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection","volume":"14","author":"Astronomo","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2020.01.002_bib9","doi-asserted-by":"crossref","first-page":"eaal2144","DOI":"10.1126\/scitranslmed.aal2144","article-title":"Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller","volume":"9","author":"Freund","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.01.002_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01187-17","article-title":"Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys","volume":"91","author":"Julg","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.002_bib11","doi-asserted-by":"crossref","first-page":"eaao4235","DOI":"10.1126\/scitranslmed.aao4235","article-title":"Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail","volume":"9","author":"Julg","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.01.002_bib12","doi-asserted-by":"crossref","first-page":"e1000433","DOI":"10.1371\/journal.ppat.1000433","article-title":"Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers","volume":"5","author":"Hessell","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2020.01.002_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nm.4063","article-title":"Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques","volume":"22","author":"Hessell","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.01.002_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"Caskey","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.01.002_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nm.4268","article-title":"Antibody 10-1074 suppresses viremia in HIV-1-infected individuals","volume":"23","author":"Caskey","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.01.002_bib16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"Scheid","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.01.002_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature21435","article-title":"Early antibody therapy can induce long-lasting immunity to SHIV","volume":"543","author":"Nishimura","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.01.002_bib18","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1128\/JVI.75.17.8340-8347.2001","article-title":"Antibody protects macaques against vaginal challenge with a pathogenic R5 simian\/human immunodeficiency virus at serum levels giving complete neutralization in\u00a0vitro","volume":"75","author":"Parren","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.002_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nm833","article-title":"Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120","volume":"9","author":"Veazey","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.01.002_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1095\/biolreprod54.1.264","article-title":"Residence half-life of IgG administered topically to the mouse vagina","volume":"54","author":"Sherwood","year":"1996","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ymthe.2020.01.002_bib21","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1038\/s41467-018-06508-3","article-title":"Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection","volume":"9","author":"Tiwari","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2020.01.002_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.theriogenology.2007.09.021","article-title":"The pregnant sheep as a model for human pregnancy","volume":"69","author":"Barry","year":"2008","journal-title":"Theriogenology"},{"key":"10.1016\/j.ymthe.2020.01.002_bib23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0300-9629(91)90307-X","article-title":"Cardiopulmonary reference standards in the pregnant sheep (Ovis aries): a comparative study of ovine and human physiology in obstetrics","volume":"100","author":"Cissik","year":"1991","journal-title":"Comp. Biochem. Physiol. A Comp. Physiol."},{"key":"10.1016\/j.ymthe.2020.01.002_bib24","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1128\/AAC.04954-14","article-title":"The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides","volume":"59","author":"Holt","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymthe.2020.01.002_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/OLQ.0b013e31819496e4","article-title":"High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides","volume":"36","author":"Vincent","year":"2009","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.ymthe.2020.01.002_bib26","article-title":"Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV\/SIV Infection","volume":"62","author":"Xiao","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymthe.2020.01.002_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/17425247.2014.901308","article-title":"Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines","volume":"11","author":"Deering","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ymthe.2020.01.002_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2012.202","article-title":"Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines","volume":"21","author":"Pollard","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.002_bib29","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.biomaterials.2013.05.039","article-title":"Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake","volume":"34","author":"Ensign","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2020.01.002_bib30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","article-title":"Nanoparticle-based drug delivery to the vagina: a review","volume":"190","author":"Ensign","year":"2014","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2020.01.002_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx290","article-title":"Characterizing exogenous mRNA delivery, trafficking, cytoplasmic release and RNA-protein correlations at the level of single cells","volume":"45","author":"Kirschman","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2020.01.002_bib32","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1021\/acs.bioconjchem.8b00443","article-title":"In\u00a0Vitro Transcribed mRNA Vaccines with Programmable Stimulation of Innate Immunity","volume":"29","author":"Loomis","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ymthe.2020.01.002_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.biomaterials.2018.01.010","article-title":"Unifying in\u00a0vitro and in\u00a0vivo IVT mRNA expression discrepancies in skeletal muscle via mechanotransduction","volume":"159","author":"Bhosle","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2020.01.002_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.virol.2011.12.009","article-title":"Glycosyl-phosphatidylinositol (GPI)-anchored membrane association of the porcine reproductive and respiratory syndrome virus GP4 glycoprotein and its co-localization with CD163 in lipid rafts","volume":"424","author":"Du","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2020.01.002_bib35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4049\/jimmunol.152.2.676","article-title":"Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1","volume":"152","author":"Nickells","year":"1994","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2020.01.002_bib36","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/JVI.00347-16","article-title":"Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies","volume":"90","author":"von Bredow","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.002_bib37","doi-asserted-by":"crossref","first-page":"rs2","DOI":"10.1126\/scisignal.2005966","article-title":"An analysis of critical factors for quantitative immunoblotting","volume":"8","author":"Janes","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2020.01.002_bib38","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.4049\/jimmunol.165.7.3999","article-title":"Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack","volume":"165","author":"Brodbeck","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2020.01.002_bib39","doi-asserted-by":"crossref","unstructured":"Lindsay, K.E., Bhosle, S.M., Zurla, C., Beyersdorf, J., Rogers, K.A., Vanover, D., et\u00a0al. Visualization of early events in mRNA vaccine delivery in non-human primates via PET-CT and near-infrared imaging. Nat. Biomed. Eng. 3, 371\u2013380.","DOI":"10.1038\/s41551-019-0378-3"},{"key":"10.1016\/j.ymthe.2020.01.002_bib40","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1128\/JVI.02066-08","article-title":"Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection","volume":"83","author":"Siddappa","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.002_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.molcel.2009.04.028","article-title":"An unfolded CH1 domain controls the assembly and secretion of IgG antibodies","volume":"34","author":"Feige","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2020.01.002_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/187221109789105658","article-title":"Mucoadhesive vaginal drug delivery systems","volume":"3","author":"Acart\u00fcrk","year":"2009","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.ymthe.2020.01.002_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/095632020901900401","article-title":"The future of HIV microbicides: challenges and opportunities","volume":"19","author":"Garg","year":"2009","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ymthe.2020.01.002_bib44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nm.4506","article-title":"Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women","volume":"24","author":"McKinnon","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.01.002_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-4757-5806-1_9","article-title":"GPI-anchored protein cleavage in the regulation of transmembrane signals","volume":"37","author":"Sharom","year":"2004","journal-title":"Subcell Biochem."},{"key":"10.1016\/j.ymthe.2020.01.002_bib46","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/emboj.2009.392","article-title":"GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells","volume":"29","author":"Speare","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2020.01.002_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.7541557","article-title":"In\u00a0vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium","volume":"269","author":"Kooyman","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.01.002_bib48","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1126\/science.aag0491","article-title":"Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus","volume":"353","author":"Liu","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.01.002_bib49","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/nar\/gkp1060","article-title":"Chain and conformation stability of solid-state DNA: implications for room temperature storage","volume":"38","author":"Bonnet","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2020.01.002_bib50","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/JVI.03136-14","article-title":"Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes","volume":"89","author":"Kong","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.002_bib51","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1128\/JVI.06745-11","article-title":"HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes","volume":"86","author":"Doria-Rose","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.002_bib52","doi-asserted-by":"crossref","first-page":"13910","DOI":"10.1128\/JVI.02083-14","article-title":"Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies","volume":"88","author":"Bouvin-Pley","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.002_bib53","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41467-018-03335-4","article-title":"Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity","volume":"9","author":"Steinhardt","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2020.01.002_bib54","doi-asserted-by":"crossref","first-page":"12039","DOI":"10.1128\/JVI.01650-12","article-title":"A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays","volume":"86","author":"Alpert","year":"2012","journal-title":"J.\u00a0Virol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620300046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620300046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T12:11:27Z","timestamp":1727698287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620300046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1525001620300046"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.01.002","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}